PROM1 and glioblastoma: Additionally, limiting dilution assay (LDA) demonstrated that CD133/PROM1HIGH patient-derived GBM cells had a higher proportion of self-renewing stem cell populations relative to CD133/PROM1LOW cells (Fig. 1e; Additional file 1: Figure 1C).